Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples